关注
Natalia Kuzmina
Natalia Kuzmina
UTMB, Pathology Department
在 utmb.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Molecular inferences suggest multiple host shifts of rabies viruses from bats to mesocarnivores in Arizona during 2001–2009
IV Kuzmin, M Shi, LA Orciari, PA Yager, A Velasco-Villa, NA Kuzmina, ...
PLoS pathogens 8 (6), e1002786, 2012
1932012
Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection
AI Flyak, X Shen, CD Murin, HL Turner, JA David, ML Fusco, R Lampley, ...
Cell 164 (3), 392-405, 2016
1742016
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
AG Letizia, Y Ge, S Vangeti, C Goforth, DL Weir, NA Kuzmina, ...
The Lancet Respiratory Medicine 9 (7), 712-720, 2021
1672021
Raccoon rabies virus variant transmission through solid organ transplantation
NM Vora, SV Basavaraju, KA Feldman, CD Paddock, L Orciari, ...
Jama 310 (4), 398-407, 2013
119*2013
Antibody-dependent enhancement of Ebola virus infection by human antibodies isolated from survivors
NA Kuzmina, P Younan, P Gilchuk, RI Santos, AI Flyak, PA Ilinykh, ...
Cell reports 24 (7), 1802-1815. e5, 2018
872018
Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization
P Gilchuk, CD Murin, JC Milligan, RW Cross, CE Mire, PA Ilinykh, ...
Immunity 52 (2), 388-403. e12, 2020
812020
Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the ebolavirus glycoprotein
P Gilchuk, N Kuzmina, PA Ilinykh, K Huang, BM Gunn, A Bryan, ...
Immunity 49 (2), 363-374. e10, 2018
742018
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region
AI Flyak, N Kuzmina, CD Murin, C Bryan, E Davidson, P Gilchuk, ...
Nature microbiology 3 (6), 670-677, 2018
742018
Conservation of binding epitopes for monoclonal antibodies on the rabies virus glycoprotein
NA Kuzmina, IV Kuzmin, JA Ellison, CE Rupprecht
J Antivir Antiretrovir 5 (2), 37-43, 2013
592013
Non-neutralizing antibodies from a Marburg infection survivor mediate protection by Fc-effector functions and by enhancing efficacy of other antibodies
PA Ilinykh, K Huang, RI Santos, P Gilchuk, BM Gunn, MM Karim, J Liang, ...
Cell host & microbe 27 (6), 976-991. e11, 2020
482020
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
P Maisonnasse, Y Aldon, A Marc, R Marlin, N Dereuddre-Bosquet, ...
Nature communications 12 (1), 6097, 2021
452021
Chimeric filoviruses for identification and characterization of monoclonal antibodies
PA Ilinykh, X Shen, AI Flyak, N Kuzmina, TG Ksiazek, JE Crowe Jr, ...
Journal of virology 90 (8), 3890-3901, 2016
452016
The phylogeography and spatiotemporal spread of south-central skunk rabies virus
NA Kuzmina, P Lemey, IV Kuzmin, BC Mayes, JA Ellison, LA Orciari, ...
PloS one 8 (12), e82348, 2013
452013
Phylogenetic and epidemiologic evidence of multiyear incubation in human rabies
TA Boland, D McGuone, J Jindal, M Rocha, M Cumming, CE Rupprecht, ...
Annals of neurology 75 (1), 155-160, 2014
442014
Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2
DF Lake, AJ Roeder, E Kaleta, P Jasbi, K Pfeffer, C Koelbela, ...
Journal of Clinical Virology 145, 105024, 2021
402021
A reassessment of the evolutionary timescale of bat rabies viruses based upon glycoprotein gene sequences
NA Kuzmina, IV Kuzmin, JA Ellison, ST Taylor, DL Bergman, B Dew, ...
Virus Genes 47, 305-310, 2013
392013
Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022
C Atyeo, MD Slein, S Fischinger, J Burke, A Schäfer, SR Leist, ...
JCI insight 6 (1), 2021
362021
Ebola vaccine–induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects
M Meyer, BM Gunn, DC Malherbe, K Gangavarapu, A Yoshida, ...
Science translational medicine 13 (602), eabg6128, 2021
302021
Asymptomatic SARS-CoV-2 infection is associated with higher levels of serum IL-17C, matrix metalloproteinase 10 and fibroblast growth factors than mild symptomatic COVID-19
A Soares-Schanoski, N Sauerwald, CW Goforth, S Periasamy, DL Weir, ...
Frontiers in Immunology 13, 821730, 2022
282022
Bat rabies in Guatemala
JA Ellison, AT Gilbert, S Recuenco, D Moran, DA Alvarez, N Kuzmina, ...
PLoS Neglected Tropical Diseases 8 (7), e3070, 2014
262014
系统目前无法执行此操作,请稍后再试。
文章 1–20